Calendar
June 2017
M T W T F S S
« May    
 1234
567891011
12131415161718
19202122232425
2627282930  
Archive

Defymed enters partnership with Semma Therapeutics

Strasbourg, December 12, 2016 – Defymed announces a strategic collaboration with Semma Therapeutics, an American biotechnology company specialising in the development of cell therapies for the treatment of diabetes, with the goal of developing of an innovative solution for treating type-1 diabetes. The collaboration is aimed at pre-clinical validation of the MAILPAN® bio-artificial pancreas, in combination with
Read full post »

Defymed winner of the Medstartup-Galien Awards 2016

DEFYMED October 27, 2016 – New York. Defymed is the winner at the Medstartup- Galien Awards 2016 – Category ” Best Innovative trial design leading to quicker and better therapeutic outcome”.  In this contest, Defymed collaborates with Semma Therapeutics to obtain a preclinical validation of stem cell derived insulin secreting cells in the bioartificial pancreas MAILPAN®.
Read full post »

Defymed and Symbiose biomaterials funded for the CODEPI project

October 26, 2016. DEFYMED and Symbiose Biomaterials SA, a Belgian startup company specialised in the development of products based on molecular biomimetics, mounted the CODEPI project. This project, cofunded by the Alsace and Wallonian regions, with the help of the health clusters Alsace Biovalley and BIOWIN, aims to develop a compress impregnated with a formulation based on
Read full post »

« recently published news · previously published news »